Neural transplantation has been investigated experimentally and clinically for the purpose of developing new treatment options for intractable epilepsy. In the present study we assessed the anticonvulsant efficacy and safety of bilateral allotransplantation of genetically engineered striatal GABAergic rat cell lines into the substantia nigra pars reticulata (SNr). Rats with previously-established seizures, induced by amygdala kindling, were used as a model of temporal lobe epilepsy. Three cell lines were transplanted: (1) immortalized GABAergic cells (M213-2O) derived from embryonic rat striatum; (2) M213-2O cells (CL4) transfected with human GAD67 cDNA to obtain higher GABA synthesis than the parent cell line; and (3) control cells (121-1I), also derived from embryonic rat striatum, but which did not show GAD expression. A second control group received injections of medium alone. Transplantation of M213-2O cells into the SNr of kindled rats resulted in significant but transient anticonvulsant effects. Neither control cells nor medium induced anticonvulsant effects. Strong tissue reactions were, however, induced in the host brain of kindled but not of non-kindled rats, and only in animals that received grafts of genetically modified CL4 cells. These tissue reactions included graft rejection, massive infiltration of inflammatory immune cells, and gliosis. The anticonvulsant effect of M213-2O cells emphasizes the feasibility of local manipulations of seizures by intranigral transplantation of GABA-producing cells. On the other hand, the present data suggest that kindling-induced activation of microglia in the SNr can enhance immune reactions to transplanted cells. In this case, under conditions of further immunological stimulation by CL4 cells, transfected with a human cDNA, substantial immune reactions occurred. Thus, it appears that the condition of the host brain and the production of foreign proteins by transplanted cells have to be considered in estimating the risks of rejection of transplants into the brain.
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Introduction
Several attempts have been made to develop new treatment options for difficult-to-treat types of seizures, such as complex partial seizures associated with temporal lobe epilepsy. Neural transplantation of cells of various types is one approach which has been investigated in a variety of experimental seizure models (for review see Björklund and Lindvall, 2000; Boison, 2005; Löscher et al., 2008; Raedt et al., 2007; Turner and Shetty, 2003) and in a few epilepsy patients (Schachter et al., 1998) . One aim of neural transplantation in intractable epilepsy is to correct a presumed imbalance between excitatory and inhibitory neurotransmission in the epileptic brain. Thus, seizures might be suppressed by transplanting cells that continuously release an inhibitory transmitter such as GABA into appropriate brain regions.
The pars reticulata of the substantia nigra (SNr) is believed to be an important brain site involved in the control of several types of experimental seizures, including electrically kindled seizures (Depaulis et al., 1994; Deransart and Depaulis, 2002; Iadarola and Gale,1982; McNamara et al., 1986; Morimoto and Goddard, 1987; Velísková and Moshé, 2006) . Kindled seizures induced by electrical stimulation of limbic structures in rats (Goddard et al., 1969 ) is one of the most widely used models of temporal lobe epilepsy (Bertram, 2007) . In contrast to post-status epilepticus models of temporal lobe epilepsy, no loss of GABAergic neurons was detected in the SNr of kindled rats (Freichel et al., 2004) . Nevertheless, abnormal GABAergic function in the SNr may be involved in the epileptic network underlying kindling (Gernert et al., 2004; Löscher and Schwark, 1985; Löscher and Schwark, 1987) . Accordingly, profound modifications of neuronal activity in the SNr and related 
